Time-series modeling of multiple sclerosis disease activity: A promising window on disease progression and repair potential?
暂无分享,去创建一个
[1] F. Barkhof,et al. Patterns of enhancing lesion evolution in multiple sclerosis are uniform within patients , 2005, Neurology.
[2] J. Oger,et al. Multiple sclerosis , 1988, Neurology.
[3] Dominik S. Meier,et al. Time-series analysis of MRI intensity patterns in multiple sclerosis , 2003, NeuroImage.
[4] F. Barkhof,et al. Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis , 1996, Annals of neurology.
[5] B Bass,et al. The natural history of multiple sclerosis: a geographically based study. 2. Predictive value of the early clinical course. , 1989, Brain : a journal of neurology.
[6] F. Barkhof,et al. Correlations between monthly enhanced MRI Lesion rate and changes in T2 Lesion volume in multiple sclerosis , 1998, Annals of neurology.
[7] Hans Lassmann,et al. Recent neuropathological findings in MS—implications for diagnosis and therapy , 2004, Journal of Neurology.
[8] J. Parisi,et al. Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination , 2000, Annals of neurology.
[9] Hans Lassmann,et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. , 2005, Brain : a journal of neurology.
[10] O. Andersen,et al. Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up. , 1993, Brain : a journal of neurology.
[11] C. Granger,et al. Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosis , 1996, Annals of neurology.
[12] F. Jolesz,et al. MRI contrast uptake in new lesions in relapsing-remitting MS followed at weekly intervals , 2003, Neurology.
[13] Richard H. Price,et al. Black Holes , 1997 .
[14] J. Baskerville,et al. The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis. , 1999, Brain : a journal of neurology.
[15] Iraj Derakhshan. Improving hand function in chronic stroke: topography of the lesion and role of the corpus callosum. , 2003, Archives of neurology.
[16] David H. Miller,et al. A longitudinal study of abnormalities on MRI and disability from multiple sclerosis. , 2002, The New England journal of medicine.
[17] F. Barkhof,et al. Longitudinal brain volume measurement in multiple sclerosis: rate of brain atrophy is independent of the disease subtype. , 2002, Archives of neurology.
[18] G J Barker,et al. The effect of interferon beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosis. European Study Group on Interferon beta-1b in secondary progressive multiple sclerosis. , 2000, Brain : a journal of neurology.
[19] B Bass,et al. The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. , 1989, Brain : a journal of neurology.
[20] R. Rudick,et al. Significance of T2 lesions in multiple sclerosis: A 13‐year longitudinal study , 2006, Annals of neurology.
[21] R Kikinis,et al. Changes in activated T cells in the blood correlate with disease activity in multiple sclerosis. , 2000, Archives of neurology.
[22] H. Tremlett,et al. Is late-onset multiple sclerosis associated with a worse outcome? , 2006, Neurology.
[23] L. L. Cook,et al. Resolution-Dependent Estimates of Multiple Sclerosis Lesion Loads , 2005, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[24] B. Scheithauer,et al. A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases. , 1999, Brain : a journal of neurology.
[25] David H. Miller,et al. Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain , 2004, Annals of neurology.
[26] M. Horsfield,et al. Quantitative assessment of MRI lesion load in monitoring the evolution of multiple sclerosis. , 1995, Brain : a journal of neurology.
[27] L. Kappos,et al. Long-term subcutaneous interferon beta-1a therapy in patients with relapsing-remitting MS , 2006, Neurology.
[28] Dominik S. Meier,et al. MRI time series modeling of MS lesion development , 2006, NeuroImage.
[29] M. Schwartz,et al. Protective autoimmunity and neuroprotection in inflammatory and noninflammatory neurodegenerative diseases , 2005, Journal of the Neurological Sciences.
[30] Hans Lassmann,et al. Remyelination is extensive in a subset of multiple sclerosis patients. , 2006, Brain : a journal of neurology.
[31] M. Rovaris,et al. Magnetization transfer MRI metrics predict the accumulation of disability 8 years later in patients with multiple sclerosis. , 2006, Brain : a journal of neurology.
[32] E. Cho,et al. Immunopathology of secondary‐progressive multiple sclerosis , 2001, Annals of neurology.
[33] D. Paty,et al. Magnetic resonance imaging results of the PRISMS trial: A randomized, double‐blind, placebo‐controlled study of interferon‐β1a in relapsing‐remitting multiple sclerosis , 1999 .
[34] F. Barkhof,et al. Accumulation of hypointense lesions ("black holes") on T1 spin-echo MRI correlates with disease progression in multiple sclerosis , 1996, Neurology.
[35] C. Lucchinetti,et al. A longitudinal MRI study of histopathologically defined hypointense multiple sclerosis lesions , 2001, Annals of neurology.
[36] R. Kikinis,et al. Serial magnetic resonance imaging in multiple sclerosis: correlation with attacks, disability, and disease stage , 2000, Journal of Neuroimmunology.
[37] N. Richert. Glatiramer acetate reduces the proportion of new MS lesions evolving into "black holes". , 2002, Neurology.
[38] P M Matthews,et al. Defining multiple sclerosis disease activity using MRI T2-weighted difference imaging. , 1998, Brain : a journal of neurology.
[39] F. Barkhof,et al. Axonal loss in multiple sclerosis lesions: Magnetic resonance imaging insights into substrates of disability , 1999, Annals of neurology.
[40] A J Thompson,et al. The longitudinal relation between brain lesion load and atrophy in multiple sclerosis: a 14 year follow up study , 2003, Journal of neurology, neurosurgery, and psychiatry.
[41] P. Adeleine,et al. Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process. , 2003, Brain : a journal of neurology.
[42] F. Barkhof,et al. Patterns of lesion development in multiple sclerosis: longitudinal observations with T1-weighted spin-echo and magnetization transfer MR. , 1998, AJNR. American journal of neuroradiology.
[43] M. Horsfield,et al. A multi-centre longitudinal study comparing the sensitivity of monthly MRI after standard and triple dose gadolinium-DTPA for monitoring disease activity in multiple sclerosis. Implications for phase II clinical trials. , 1998, Brain : a journal of neurology.
[44] À. Rovira,et al. Baseline MRI predicts future attacks and disability in clinically isolated syndromes , 2006, Neurology.
[45] G. Barker,et al. Effect of interferon‐β1b on magnetic resonance imaging outcomes in secondary progressive multiple sclerosis: Results of a European multicenter, randomized, double‐blind, placebo‐controlled trial , 1999 .
[46] G. Barker,et al. Quantitative MRI in patients with secondary progressive MS treated with monoclonal antibody Campath 1H , 1999, Neurology.
[47] Ludwig Kappos,et al. Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis , 1999, The Lancet.
[48] A J Thompson,et al. Is inflammation important in early PPMS? a longitudinal MRI study , 2005, Journal of Neurology, Neurosurgery & Psychiatry.
[49] M Rovaris,et al. Whole brain volume changes in patients with progressive MS treated with cladribine , 2000, Neurology.
[50] J A Frank,et al. Guidelines for using quantitative measures of brain magnetic resonance imaging abnormalities in monitoring the treatment of multiple sclerosis , 1998, Annals of neurology.
[51] D. Li,et al. Serial magnetic resonance scanning in multiple sclerosis: A second prospective study in relapsing patients , 1989, Annals of neurology.
[52] Neal Jeffries,et al. Evolution of T1 black holes in patients with multiple sclerosis imaged monthly for 4 years. , 2003, Brain : a journal of neurology.